跳至主要内容
临床试验/NCT04259632
NCT04259632已完成不适用

Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans

University of Minnesota1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2020年10月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
115
试验地点
1
主要终点
Change in Weight

研究概览

简要总结

Purpose: Obesity is reaching epidemic proportions, affecting 36% of the adult population in the United States. There is intense interest in dietary management to treat obesity and its associated complications. The first line of obesity treatment is caloric restriction (CR), although recidivism is common. For moderate CR, attrition rates of 20% are often reported, therefore weight loss options beyond CR are urgently needed.

详细描述

Aim#1: Evaluate the effect of TRE with ad libitum intake on weight and body composition.

H 1.1: Individuals in the TRE and CR groups will have similar weight loss, which will be greater than weight loss achieved in the non-TRE group (primary outcome).

H 1.2: TRE will result in greater loss of loss of total body fat (quantified by DXA) and greater loss of hepatic/visceral fat/ectopic fat (quantified by MRI) than CR.

Aim#2: Assess the effect of TRE with ad libitum intake on caloric balance. H 2.1: TRE will reduce caloric intake compared with non-TRE [gold-standard interviewer administered 24-hour dietary recall (primary outcome)] with similar reduction as with CR, H.2.2: Compared with non-TRE, TRE will result in selection of more nutrient dense foods during a supervised meal within their eating window; this selection will be similar to CR. H 2.3 TRE will not alter physical activity, but will increase fat oxidation compared with CR and non-TRE.

Aim#3: Assess the effect of TRE with ad libitum intake on metabolic flexibility.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI ≥30 and ≤ 55 kg/m^2
  • Own a smartphone compatible with the myCircadianClock (mCC) phone application
  • Self-reported habitual wakening between 5-9 am
  • Self reported sleep duration of 6-9 hours
  • Weight must be stable [+/- 5 pounds] for at least 3 months prior to the study
  • Eating window (time between 1st food intake and last food take) ≥14 hours using mCC
  • Insulin resistance based on HOMA-IR≥ 2.5 from screening visit results
  • Able to understand English

排除标准

  • Use of beta-blockers or medications known to affect weight, such as thiazolidinedione (TZD), insulin, glucagon-like peptide (GLP)-1 agonists, phentermine, or sibutamine
  • Shift work (i.e. working from 11pm to 7am)
  • Clinically significant medical issues (diabetes, cardiovascular disease, uncontrolled pulmonary disease)
  • A history of abnormal laboratory results, such as hematologic (platelets < 100), hepatic (LFTs > 2X nl), renal (Cr > 1.5)
  • MRI contraindication (metal in body, claustrophobia)
  • Eating window < 12 hours per day
  • Unable to consistently document food intake using the mCC app (need at least 2 eating occasions> 6 hours apart on a given day for at least 50% of days)
  • Pregnancy
  • Illiteracy
  • Concern for active eating disorder per screening questionnaire
  • Self-reported eating disorder or history of eating disorder

研究组 & 干预措施

Time Restricted Eating (TRE)

Experimental

For the TRE group, we will restrict the eating window to 8 hours, where they will eat ad libitum. This is the same interval established by Dr. Panda and by our preliminary data. This interval will be entered into the mCC app and participants will be asked to adhere to this eating window during the intervention. All eating occasions will be logged using the mCC app. Only water and medications will be allowed outside of the eating window.

干预措施: Time Restricted Eating (TRE) (Behavioral)

Caloric Restriction (CR)

Active Comparator

Participants randomized to CR will meet with the study dietitian prior to the intervention and be counseled on options to reduce their caloric intake by 15%, while maintaining their eating window. The 15% reduction was selected as our preliminary data and recent literature suggest that TRE with ad libitum intake reduces caloric intake by ~270 to 300 cal/day. The 15% CR is similar to the 11.9% CR achieved by the CALERIE-2 study, which is a 2 year study of CR.26 All eating occasions will be logged using the mCC app. The weekly dietitian review of the mCC information will include maintenance of the eating window and examination of dietary intake to determine compliance with the 15% CR.

干预措施: Caloric Restriction (CR) (Behavioral)

Unrestricted Eating (non-TRE)

No Intervention

For the unrestricted eating (non-TRE) group, participants will eat ad libitum per their usual habits. They will receive initial counseling about mCC logging. All eating occasions will be logged using the mCC app.

结局指标

主要结局

Change in Weight

时间窗: 12 weeks

Weight will be measured by standard scale and reported in kilograms. This between 2 time points - baseline and 12 weeks

次要结局

  • Change in Whole Body Percent Fat(Baseline, 12 weeks)
  • Change in Visceral Fat(Baseline, 12 weeks)
  • Change in Lean Mass(Baseline, 12 weeks)
  • Change in Fat Mass(Baseline, 12 weeks)
  • Change in Caloric Intake(Baseline, 12 weeks)
  • Change in Metabolic Flexibility(baseline, 12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验